Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
November 14, 2024 16:30 ET
|
GlucoTrack, Inc.
Rutherford, NJ., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for...
Stryve Foods, Inc. Announces Closing of $2.9 Million Public Offering
November 12, 2024 12:15 ET
|
Stryve Foods, Inc.
Stryve Foods, Inc. (Nasdaq: SNAX) Announces Closing of $2.9 Million Public Offering
ProPhase Labs Announces Pricing of Public Offering of Common Stock
November 07, 2024 23:37 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the...
ProPhase Labs Announces Proposed Public Offering of Common Stock
November 07, 2024 16:05 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next-generation biotech, genomics and diagnostics company, today announced that it intends to offer to sell...
CNL Strategic Capital Launches Second Follow-On Offering of $1.1 Billion
November 01, 2024 17:11 ET
|
CNL Strategic Capital
Orlando, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- CNL Strategic Capital, a public, non-traded company that seeks to provide current income and long-term appreciation to its investors, has launched...
Marex Group plc Announces Launch of a Public Offering
October 21, 2024 16:53 ET
|
Marex Group plc
MAREX GROUP PLC ANNOUNCES LAUNCH OF A PUBLIC OFFERING
Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering
September 19, 2024 16:01 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 19, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked...
Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering
September 17, 2024 17:00 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 17, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked...
Better Choice Company Inc. Announces Closing of Public Offering - Updated
July 31, 2024 16:58 ET
|
Better Choice Company, Inc.
Tampa, Florida, July 31, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or (“Better Choice”), a pet health and wellness company, today announced the closing...
Better Choice Company Inc. Announces Closing of Public Offering
July 31, 2024 16:13 ET
|
Better Choice Company, Inc.
Tampa, Florida, July 31, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or (“Better Choice”), a pet health and wellness company, today announced the closing...